These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 27034168)

  • 1. Genetic polymorphisms of immune checkpoint proteins PD-1 and TIM-3 are associated with survival of patients with hepatitis B virus-related hepatocellular carcinoma.
    Li Z; Li N; Li F; Zhou Z; Sang J; Jin Z; Liu H; Han Q; Lv Y; Liu Z
    Oncotarget; 2016 May; 7(18):26168-80. PubMed ID: 27034168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune checkpoint proteins PD-1 and TIM-3 are both highly expressed in liver tissues and correlate with their gene polymorphisms in patients with HBV-related hepatocellular carcinoma.
    Li Z; Li N; Li F; Zhou Z; Sang J; Chen Y; Han Q; Lv Y; Liu Z
    Medicine (Baltimore); 2016 Dec; 95(52):e5749. PubMed ID: 28033288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic association and interaction of PD1 and TIM3 polymorphisms in susceptibility of chronic hepatitis B virus infection and hepatocarcinogenesis.
    Li F; Fan X; Wang X; Deng H; Zhang X; Zhang K; Li N; Han Q; Lv Y; Liu Z
    Discov Med; 2019 Feb; 27(147):79-92. PubMed ID: 30939292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variations of PD1 and TIM3 are differentially and interactively associated with the development of cirrhosis and HCC in patients with chronic HBV infection.
    Li Z; Li N; Zhu Q; Zhang G; Han Q; Zhang P; Xun M; Wang Y; Zeng X; Yang C; Liu Z
    Infect Genet Evol; 2013 Mar; 14():240-6. PubMed ID: 23291409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TIM3 gene polymorphisms in patients with chronic hepatitis B virus infection: impact on disease susceptibility and hepatocellular carcinoma traits.
    Li Z; Liu Z; Zhang G; Han Q; Li N; Zhu Q; Lv Y; Chen J; Xing F; Wang Y; Li F
    Tissue Antigens; 2012 Aug; 80(2):151-7. PubMed ID: 22587604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD1 gene polymorphism is associated with a poor prognosis in hepatocellular carcinoma following liver resection, cohort study.
    Yamamoto M; Kobayashi T; Mashima H; Miki D; Kuroda S; Hamaoka M; Aikata H; Chayama K; Ohdan H
    Int J Surg; 2020 Aug; 80():84-90. PubMed ID: 32615319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking Tim-3 or/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma.
    Liu F; Zeng G; Zhou S; He X; Sun N; Zhu X; Hu A
    Bull Cancer; 2018 May; 105(5):493-501. PubMed ID: 29576222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms of HLA-DQB1 predict survival of hepatitis B virus-related hepatocellular carcinoma patients receiving hepatic resection.
    Liu X; Yu L; Han C; Lu S; Zhu G; Su H; Qin W; Liao X; Peng T
    Clin Res Hepatol Gastroenterol; 2016 Dec; 40(6):739-747. PubMed ID: 27288300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of T-cell immunoglobulin and mucin domain-containing molecule 3 (Tim-3) polymorphisms with susceptibility and disease progression of HBV infection.
    Liao J; Zhang Q; Liao Y; Cai B; Chen J; Li L; Wang L
    PLoS One; 2014; 9(5):e98280. PubMed ID: 24867713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms in the Wnt/β-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Kim SS; Cho HJ; Lee HY; Park JH; Noh CK; Shin SJ; Lee KM; Yoo BM; Lee KJ; Cho SW; Cheong JY
    Clin Biochem; 2016 Jul; 49(10-11):792-801. PubMed ID: 26968103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative Outcomes for Patients with Non-B Non-C Hepatocellular Carcinoma: A Subgroup Analysis of Patients with a History of Hepatitis B Infection.
    Omichi K; Shindoh J; Yamamoto S; Matsuyama Y; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1034-40. PubMed ID: 26350363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants of m
    Liu S; Li J; Qiu M; Liu Y; Wen Q; Lin Q; Jiang Y; Zhou Z; Liang X; Wei X; Yu H; Chen P
    J Cell Mol Med; 2024 Aug; 28(16):e18517. PubMed ID: 39163514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population.
    Kim WH; Min KT; Jeon YJ; Kwon CI; Ko KH; Park PW; Hong SP; Rim KS; Kwon SW; Hwang SG; Kim NK
    Gene; 2012 Aug; 504(1):92-7. PubMed ID: 22583825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-1 mRNA expression is associated with clinical and viral profile and PD1 3'-untranslated region polymorphism in patients with chronic HBV infection.
    Zhang G; Li N; Zhang P; Li F; Yang C; Zhu Q; Han Q; Lv Y; Zhou Z; Liu Z
    Immunol Lett; 2014 Nov; 162(1 Pt A):212-6. PubMed ID: 25218665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of LTBR polymorphisms with chronic hepatitis B virus infection and hepatitis B virus-related hepatocellular carcinoma.
    Zhu Q; Li N; Li F; Sang J; Deng H; Han Q; Lv Y; Li C; Liu Z
    Int Immunopharmacol; 2017 Aug; 49():126-131. PubMed ID: 28575727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of XRCC1/XPD/ERCC1 Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization.
    Wang XC; Wang F; Quan QQ
    Genet Test Mol Biomarkers; 2016 Apr; 20(4):176-84. PubMed ID: 26918371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 3 genetic variants and susceptibility to hepatocellular carcinoma and HBV-related hepatocellular carcinoma.
    Li G; Zheng Z
    Tumour Biol; 2013 Jun; 34(3):1589-94. PubMed ID: 23404408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of PINX1 but not TEP1 Polymorphisms with Progression to Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B Virus Infection.
    Sriprapun M; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Payungporn S; Tangkijvanich P
    Asian Pac J Cancer Prev; 2016; 17(4):2019-25. PubMed ID: 27221889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentially functional genetic variants in ferroptosis-related CREB3 and GALNT14 genes predict survival of hepatitis B virus-related hepatocellular carcinoma.
    Zhan S; Qiu M; Wei X; Wei J; Qin L; Jiang B; Wen Q; Chen P; Lin Q; Wei X; Zhou Z; Jiang Y; Liang X; Li R; Liu Y; Yu H
    Cancer Med; 2024 Jan; 13(1):e6848. PubMed ID: 38151984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.